Cita APA

Lu, M., Wang, X., Li, Y., Tripodi, J., Mosoyan, G., Mascarenhas, J., . . . Hoffman, R. (2012). Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells. American Society of Hematology.

Citación estilo Chicago

Lu, Min, Xiaoli Wang, Yan Li, Joseph Tripodi, Goar Mosoyan, John Mascarenhas, Marina Kremyanskaya, Vesna Najfeld, y Ronald Hoffman. Combination Treatment in Vitro With Nutlin, a Small-molecule Antagonist of MDM2, and Pegylated Interferon-α 2a Specifically Targets JAK2V617F-positive Polycythemia Vera Cells. American Society of Hematology, 2012.

Cita MLA

Lu, Min, et al. Combination Treatment in Vitro With Nutlin, a Small-molecule Antagonist of MDM2, and Pegylated Interferon-α 2a Specifically Targets JAK2V617F-positive Polycythemia Vera Cells. American Society of Hematology, 2012.